TARA compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

TARAProtara Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

TARAProtara Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

TARAProtara Therapeutics, Inc.

2.36· pre 2.30· delayed

Mkt cap$147.0MRevenue—Revenue—

AMGNAmgen Inc

478.34· pre 480.00· delayed

Pre-marketNov 4 '26delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Pre-marketNov 4 '26delayed

TARAProtara Therapeutics, Inc.

AMGNAmgen Inc

2.36pre 2.30delayed

Price

478.34pre 480.00delayed

$147.0M

Mkt cap

$258.8B

—

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

TARA2.36vsAMGN478.34Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

TARA, solidAMGN, dashed

Supply-chain overlap

Revenue flow

TARA: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TARA 0

None

Shared 0

No disclosed counterparties: TARA.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Role chip = supplier or customerSource: SEC EDGAR